Overview
Polysubstance dependence involves the compulsive use of three or more substances, often including alcohol and illicit drugs, leading to significant impairment or distress 1.Diagnosis
Clinical Assessment: Comprehensive evaluation including substance use history, physical examination, and psychiatric screening 1.
Laboratory Tests: Toxicology screens to identify specific substances 1.
Grading: Severity often assessed using standardized criteria like the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 1.Management
First-Line Treatments:
- Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Motivational Interviewing 1.
- Medications: Specific to co-occurring disorders (e.g., naltrexone for alcohol dependence, acamprosate) 1.
Adjunctive Treatments:
- Support Groups: Participation in groups like Alcoholics Anonymous (AA) or Narcotics Anonymous (NA) 1.
- Multidisciplinary Approach: Collaboration with psychiatrists, addiction specialists, and social workers 1.Special Populations
Pregnancy: Specialized care focusing on minimizing harm to the fetus; medication choices guided by safety profiles 1.
Pediatrics: Early intervention and family therapy; cautious use of pharmacotherapy due to developmental considerations 1.
Elderly: Tailored treatment plans considering polypharmacy risks and comorbid conditions; frequent monitoring 1.
Comorbidities: Integrated management addressing both substance use disorders and other health issues (e.g., mental health conditions, chronic pain) 1.Key Recommendations
Utilize comprehensive clinical assessments including substance use history and toxicology screens for accurate diagnosis (Evidence: Moderate 1).
Implement evidence-based behavioral therapies such as CBT and Motivational Interviewing as first-line treatments (Evidence: Moderate 1).
Consider multidisciplinary approaches involving psychiatrists and addiction specialists for optimal management (Evidence: Expert opinion 1).References
1 Arnet I, Abraham I, Messerli M, Hersberger KE. A method for calculating adherence to polypharmacy from dispensing data records. International journal of clinical pharmacy 2014. link